Founded August 2019
Stage Technology development
Investor Trendlines Medical Singapore
Contact Yong Teck Hui, Product Development Engineer
NasoTrak’s nasogastric tube (NGT) system comprises a proprietary nasogastric tube and a separate handheld, portable detector. The NGT is designed such that it is able to transmit ultrasound from within the body, which will be picked up by the handheld detector. This helps the user to determine the location of the distal end of the NGT to give a real-time, accurate and safe means of tube placement before feeding.
NasoTrak is developing the system in partnership with clinicians from the National Healthcare Group (one of the major healthcare clusters in Singapore) and Trendlines Labs.
Filed provisional patent
Biomedical engineer with experience in product design
Commonly used methods for detecting correct NGT placement are pH aspirates and X-rays. However, these methods are not foolproof: pH aspirates cannot be immediately drawn in more than 50% of patients and misinterpretation of X-rays were responsible for 45% of misplacements¹.
In 2017, 40 million NG tubes were used annually for an estimated total market of $385 million. The global NGT market is expected to have a CAGR of 6%, reaching ~$546 million in 2022².
¹ Esther Monica Peijin Fan, Singapore General Hospital, Proceedings of Singapore Healthcare (2017): Nasogastric tube placement confirmation: where we are and where we should be heading
² Global Market Insights
